International Agency for Research on Cancer

The August 2008 issue of The Lancet Oncology includes an article entitled “Special Report: Policy — Future Priorities for IARC Monographs.” According to the article, carbon-based nanomaterials and ultrafine particles are included on the list of substances recommended by the International Agency for Research on Cancer (IARC) Advisory Group as high priority for assessment. The article

The International Agency for Research on Cancer (IARC) recently solicited nominations for substances for review in future IARC Monographs, which identify environmental factors that can increase the risk of human cancer. IARC states that it will select substances for review based on: (a) evidence of human exposure; and (b) evidence or suspicion of carcinogenicity. The 51 substances nominated include carbon nanotubes, which received three nominations:
Continue Reading